AdobeStock_171759632

Solutions globales de surveillance immunitaire

Une gamme de solutions complètes de surveillance immunitaire à la pointe de l'industrie

Precision fournit des services complets de surveillance immunitaire, depuis le développement de tests personnalisés pour les premières études cliniques jusqu'à la gestion des besoins logistiques et des tests de surveillance immunitaire pour les essais d'homologation à l'échelle mondiale. Nous exploitons de multiples plateformes technologiques à l'échelle mondiale, y compris des innovations exclusives comme Epiontis ^ID®.

Explorer

Cytométrie en flux

Cytométrie en flux standard et spectrale, sur des instruments de qualité recherche et validés CLIA

Explorer

Cytométrie en flux

Cytométrie en flux standard et spectrale, sur des instruments de qualité recherche et validés CLIA

Explorer
Explorer

Profilage cellulaire épigénétique Epiontis ID

La technologie de surveillance immunitaire brevetée de Precision, qui permet un phénotypage robuste, reproductible et rentable des cellules immunitaires sur n'importe quel type d'échantillon.

Explorer

Profilage cellulaire épigénétique Epiontis ID

La technologie de surveillance immunitaire brevetée de Precision, qui permet un phénotypage robuste, reproductible et rentable des cellules immunitaires sur n'importe quel type d'échantillon.

Explorer
Explorer

Profilage des cytokines et protéomique

Essais personnalisés pour détecter les cytokines ou les protéines d'intérêt par ELISA, Luminex, MSD, SIMOA et Western Blotting.

Explorer

Profilage des cytokines et protéomique

Essais personnalisés pour détecter les cytokines ou les protéines d'intérêt par ELISA, Luminex, MSD, SIMOA et Western Blotting.

Explorer
Explorer

ELISpot et Fluorospot

ELISpot et FluoroSpot - y compris des tests personnalisés pour l'immunogénicité des thérapies géniques - de la phase préclinique à la phase de développement clinique.

Explorer

ELISpot et Fluorospot

ELISpot et FluoroSpot - y compris des tests personnalisés pour l'immunogénicité des thérapies géniques - de la phase préclinique à la phase de développement clinique.

Explorer
Explorer

Essais sur cellules

Développement et qualification de modèles cellulaires humains in vitro en 2D et 3D utilisant un large éventail de types de cellules primaires humaines, avec une analyse permettant d'obtenir une variété de résultats.

Explorer

Essais sur cellules

Développement et qualification de modèles cellulaires humains in vitro en 2D et 3D utilisant un large éventail de types de cellules primaires humaines, avec une analyse permettant d'obtenir une variété de résultats.

Explorer
Explorer

Profilage de l'expression génétique des biopsies

Comprendre l'expression des cibles, les réponses immunitaires adaptatives et innées au niveau de l'expression des gènes. Les technologies que nous utilisons pour le profilage de l'expression des gènes comprennent NanoString, Illumina RNA-seq, ddPCR et qPCR.

Explorer

Profilage de l'expression génétique des biopsies

Comprendre l'expression des cibles, les réponses immunitaires adaptatives et innées au niveau de l'expression des gènes. Les technologies que nous utilisons pour le profilage de l'expression des gènes comprennent NanoString, Illumina RNA-seq, ddPCR et qPCR.

Explorer

Logistique des échantillons cliniques et biostockage

Nous disposons d'un dépôt biologique de 100 000 pieds carrés, qui comprend notre campus de 140 000 pieds carrés à Frederick, dans le Maryland, et nos installations mondiales de logistique et de biobanque à Berlin, en Allemagne. Ce vaste réseau a été le premier à recevoir la certification CAP. Actuellement, nous sommes responsables du stockage de plus de 20 millions d'échantillons biologiques dans des conditions contrôlées. Nous pouvons accueillir tout type de spécimen biologique fluide ou solide à des températures ambiantes contrôlées, +4℃, -20℃, -80℃, ou dans de la vapeur d'azote liquide.

Le biorepository comprend de nombreux dispositifs de sécurité et de sûreté :

Systèmes de secours redondants, unités de secours dédiées
Surveillance automatisée de la température 24 heures sur 24
Techniciens CVC internes, spécialisés dans la réfrigération en cascade

Ressources connexes

Brochure
Immune Monitoring Solutions
Download Brochure
Whitepaper
To flow or not to flow: Immune cell profiling in translational research
Download Whitepaper
Whitepaper
Guide to Immune Monitoring
Download Whitepaper
Brochure
Epiontis ID: Use Cases Across Diverse Therapeutic Areas
Download Brochure

Blog - Ut libero ura, finibus sed tortor nec, fringilla blandit est

Nullam fermentum, massa vel lacinia pellentesque, nulla erat condimentum ipsum, ac blandit sapien neque sed sem. Quisque bibendum semper erat, nec luctus ligula.

Visiter le blog

Case Study: Theranostic Radiopharm Trial and Evolving FDA Expectations

Case Study: Theranostic Radiopharm Trial and Evolving FDA Expectations

juil. 20, ‘26 | 9 min read

has not third author: true, (SizeLimitingPyMap: {main={hs_id=217320686763, hs_child_table_id=0, hs_updated_at=1784229018395, hs_published_at=1784230314171, description=Rachel Piacente is a Clinical Trial Manager at Precision for Medicine with over 15 years of clinical research experience.  She specializes in oncology, hematology, cell and gene therapy, CAR-T, radiopharmaceuticals, and multinational Phase I–IV trials.  Rachel has proven expertise in trial operations, site management, regulatory compliance, budgeting, vendor oversight, and cross-functional team leadership across US and global studies., avatar=Image{width=1010,height=1305,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Rachel%20Piacente_pic.jpg',altText='Rachel Piacente_pic',fileId=217303397279}, lastname=Piacente, hs_initial_published_at=1784230182153, hs_created_by_user_id=65712240, hs_created_at=1784228917126, hs_is_edited=false, hs_deleted_at=0, name=Rachel, job=Clinical Trial Manager , slug=rachel-piacente, hs_updated_by_user_id=51739740}, second={hs_id=217314606343, hs_child_table_id=0, hs_updated_at=1784229356581, hs_published_at=1784230314171, description=Jennifer Coates is a Project Manager at Precision for Medicine with over a decade of clinical research experience supporting global clinical trials across multiple phases of development and a broad spectrum of therapeutic areas. She specializes in driving the successful execution of theranostic and other complex clinical programs, providing operational leadership to cross-functional teams while ensuring compliance with regulatory requirements and quality standards. Jennifer is known for fostering strong partnerships with sponsors and study teams, enabling collaboration, operational excellence, and the production of high-quality project deliverables., avatar=Image{width=2185,height=3261,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/JenCoates.jpeg',altText='JenCoates',fileId=217308893107}, lastname=Coates, hs_initial_published_at=1784230182153, hs_created_by_user_id=65712240, hs_created_at=1784228926906, hs_is_edited=false, hs_deleted_at=0, name=Jennifer, job=Project Manager, slug=jennifer-coates, hs_updated_by_user_id=51739740}, third={}})

Rachel P.
Jennifer C.

Découvrir

Why APAC Is Becoming a Design Decision

Clinical Trials

Why APAC Is Becoming a Design Decision

juil. 16, ‘26 | 8 min read

has third author: false, (SizeLimitingPyMap: {main={hs_id=199521241215, hs_child_table_id=0, hs_updated_at=1774887081250, hs_published_at=1784230314171, description=An industry veteran with nearly three decades of experience in the clinical research industry and deep expertise in clinical operations and strategic leadership across both pharmaceutical and CRO environments. Held pivotal roles as Head of Clinical Operations for Greater China at Boehringer Ingelheim, leading trials in oncology, respiratory, stroke, and cardio-metabolic diseases and CEO of George Clinical, a global CRO with strong scientific capabilities in renal and oncology therapeutic areas. At Precision for Medicine, a leader for business strategy across the Asia Pacific region. Focused on driving regional growth, building strategic partnerships, and supporting excellence in portfolio delivery and client satisfaction. An acknowledged driver of precision-driven solutions that improve patient outcomes., avatar=Image{width=276,height=290,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/James%20Cheong.png',altText='James Cheong',fileId=199519079710}, linkedin=https://www.linkedin.com/in/james-cheong-36a543a/, lastname=Cheong, hs_initial_published_at=1762885727645, hs_created_by_user_id=78347666, hs_created_at=1762885637470, hs_is_edited=false, hs_deleted_at=0, name=James, job=Senior Vice President, Asia Pacific, Clinical Solutions, slug=james-cheong, hs_updated_by_user_id=51739740}, second={hs_id=199519203221, hs_child_table_id=0, hs_updated_at=1770145994248, hs_published_at=1784230314171, description=Highly accomplished global clinical operations executive with nearly three decades of experience providing strategic leadership, regional expansion, and operational excellence across Asia Pacific. Brings deep expertise across clinical development, project and portfolio operations, biometrics, regulatory affairs, safety and pharmacovigilance, quality management, and financial governance. Proven builder and scaler of high‑performing teams and start‑up operations in both regional and global environments. Recognized industry leader who actively contributes to advancing clinical research standards through advisory and governance roles across Asia., avatar=Image{width=276,height=290,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Jing%20Ping%20Yeo.png',altText='Jing Ping Yeo',fileId=199530854290}, linkedin=https://www.linkedin.com/in/jing-ping-yeo/, lastname=Yeo, PhD , hs_initial_published_at=1762893310168, hs_created_by_user_id=78347666, hs_created_at=1762893091367, hs_is_edited=false, hs_deleted_at=0, name=Jing Ping, job=Vice President, Clinical Operations, Head of Asia Pacific, slug=JingPing-Yeo, hs_updated_by_user_id=51739740}, third={hs_id=199528025104, hs_child_table_id=0, hs_updated_at=1774885968488, hs_published_at=1784230314171, description=With 20+ years of experience in the clinical trial industry, he has led project management, clinical operations, and business development teams. Prior to joining Precision, he served as the General Manager of Emerald (formerly George Clinical) China, and held project management and business development leadership roles at ICON, WuXi CDS, IQVIA, and KUNTUO. He has successfully led teams to complete more than 120 Phase I–IV clinical trials, many of which were MRCT studies across Asia‑Pacific, Australia, and the United States. He holds a Master’s degree in Urology from Peking University First Hospital., avatar=Image{width=276,height=290,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Zhenfei%20Yin.png',altText='Zhenfei Yin',fileId=199530854553}, lastname=Yin, hs_initial_published_at=1762893310168, hs_created_by_user_id=78347666, hs_created_at=1762893190542, hs_is_edited=false, hs_deleted_at=0, name=Zhenfei, job=China Country Head, Senior Director, Project Management, slug=Zhenfei Yin, hs_updated_by_user_id=51739740}})

James C.

Jing Ping Y.

Zhenfei Y.

Découvrir

Case Study: Delivering an Early-Phase Autoimmune Trial Across Regions

Clinical Trials - Early Phase Research - Autoimmune

Case Study: Delivering an Early-Phase Autoimmune Trial Across Regions

juin 11, ‘26 | 8 min read

has third author: false, (SizeLimitingPyMap: {main={hs_id=214928090133, hs_child_table_id=0, hs_updated_at=1781285625399, hs_published_at=1784230314171, description=Deborah Spencer is a Senior Director of Project Management at Precision for Medicine with over 25 years of experience in clinical research. She specialises in leading global clinical trials across multiple phases, with deep expertise in complex study delivery. Deborah provides strategic oversight of programmes, leads high-performing teams, and partners closely with sponsors to ensure successful execution and regulatory readiness., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Deborah%20Spencer.jpg',altText='Deborah Spencer',fileId=214838919278}, lastname=Spencer, hs_initial_published_at=1781285742914, hs_created_by_user_id=26433386, hs_created_at=1781285562019, hs_is_edited=false, hs_deleted_at=0, name=Deborah, job=Senior Director, Project Management, slug=deborah-spencer, hs_updated_by_user_id=51739740}, second={hs_id=214928170660, hs_child_table_id=0, hs_updated_at=1781285676367, hs_published_at=1784230314171, description=Anthea Gates is a Project Director with approximately 30 years of drug development and medical device industry expertise across all phases, over a variety of indications including breast, lung cancer, solid tumors and lymphoma, cutaneous T-cell lymphoma, malignant melanoma, squamous cell carcinoma, rare haematologic disease, autoimmune rheumatology, osteoarthritis, ocular burns, liver cirrhosis, myopia and pre-eclampsia.  Committed to delivering quality and passionate about building positive relationships with clients and study teams to promote cohesive business practices and ensure the successful management of projects from start to finish. Anthea holds a proven track record in effective leadership of cross-functional teams across programs of studies, to the accomplishment of operational excellence., avatar=Image{width=372,height=546,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/profile.jpg',altText='profile',fileId=214846873938}, lastname=Gates, hs_initial_published_at=1781285742914, hs_created_by_user_id=26433386, hs_created_at=1781285639221, hs_is_edited=false, hs_deleted_at=0, name=Anthea, job=Project Director, slug=anthea-gates, hs_updated_by_user_id=51739740}, third={hs_id=214928090141, hs_child_table_id=0, hs_updated_at=1781285738567, hs_published_at=1784230314171, description=Claire Delaville is a Senior Project Manager at Precision for Medicine. She brings 18 years of experience across preclinical and clinical research, including more than a decade leading Phase I to IV studies in oncology, rare diseases, and immunology, with direct experience in first-in-human and multicenter oncology trials. Claire is responsible for maintaining study quality through inspection readiness, corrective action planning, and proactive risk mitigation. She also oversees study budgets and vendor performance to support coordinated delivery across functions, drawing on a scientific foundation that includes a PhD in Neurosciences and Neuropharmacology. Based in Paris, France, Claire aligns scientific insight with operational execution to support successful trial outcomes., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Claire%20Delaville.jpg',altText='Claire Delaville',fileId=214838927033}, lastname=Delaville, hs_initial_published_at=1781285742914, hs_created_by_user_id=26433386, hs_created_at=1781285678112, hs_is_edited=false, hs_deleted_at=0, name=Claire, job=Senior Project Manager, slug=claire-delaville, hs_updated_by_user_id=51739740}})

Deborah S.

Anthea G.

Claire D.

Découvrir